GO2 in T-Prolymphocytic Leukemia: Deregulation and Function | Oncotarget

Posted by

Oncotarget

Oncotarget published this editorial on July 20, 2023 in Volume 14, entitled, “AGO2 in T-prolymphocytic leukemia: its canonical and noncanonical deregulation and function” by researchers from Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aa-chen-Bonn-CologneDuesseldorf, University of Cologne, Cologne, Germany; Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, Leipzig, Germany. DOI - https://doi.org/10.18632/oncotarget.28378 Correspondence to - Marco Herling - marco.herling@medizin.uni-leipzig.de Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28378 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, leukemia, T-PLL, AGO2, microRNA About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957